Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2000 Aug;31(2):347-82.
doi: 10.1086/313954. Epub 2000 Sep 7.

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

Affiliations
Guideline

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

J G Bartlett et al. Clin Infect Dis. 2000 Aug.
No abstract available

PubMed Disclaimer

Figures

Table 1
Table 1
Categories for ranking recommendations in the therapeutic guidelines.
Figure 1
Figure 1
Evaluation for diagnosis and management of community-acquired pneumonia, including site, duration, and type of treatment. β-Lactam: cefotaxime, ceftriaxone, or a β-lactam / β-lactamase inhibitor. Fluoroquinolone: levofloxacin, moxifloxacin, or gatifloxacin or another fluoroquinolone with enhanced antipneumococcal activity. Macrolide: erythromycin, clarithromycin, or azithromycin. CBC, complete blood cell count; ICU, intensive care unit. *Other tests for selected patients: see text, Diagnostic Evaluation: Etiology. **See table 15 for special considerations.
Table 2
Table 2
Comparison of risk class-specific mortality rates in the derivation and validation cohorts.
Table 3
Table 3
Scoring system for step 2 of the prediction rule: assignment to risk classes II–V
Table 4
Table 4
Risk-class mortality rates.
Table 5
Table 5
Diagnostic studies for evaluation of community-acquired pneumonia.
Table 6
Table 6
Rationale for establishing an etiologic diagnosis.
Table 7
Table 7
Epidemiological conditions related to specific pathogens in patients with selected community-acquired pneumonia.
Table 8
Table 8
Recommendations for expectorated sputum collection, transport, and processing.
Table 9
Table 9
Diagnostic studies for specific agents of community-acquired pneumonia.
Table 10
Table 10
Diagnostic accuracy of microbial pathogens recovered from respiratory secretions.
Figure 2
Figure 2
Procedures for diagnosis and for outpatient and hospital-centered management of community-acquired pneumonia in adults.
Table 11
Table 11
Susceptibility of Streptococcus pneumoniae to commonly used antimicrobial agents, stratified by susceptibility to penicillin.
Table 12
Table 12
Characteristics of the various forms of aspiration pneumonia.
Table 13
Table 13
Biological warfare agents that would cause pulmonary disease.
Table 14
Table 14
Pathogen-directed antimicrobial therapy for community-acquired pneumonia.
Table 15
Table 15
Empirical selection of antimicrobial agents for treating patients with community-acquired pneumonia.
Figure 3
Figure 3
Possible factors to be considered when patients fail to respond or their conditions deteriorate after initiation of empirical therapy

Comment in

References

    1. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial empiric therapy of community-acquired pneumonia: proceedings of an American Thoracic Society Consensus Conference. Am Rev Resp Dis. 1993;148:1418–26. - PubMed
    1. British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med. 1993;49:346–50. - PubMed
    1. Mandell LA, Niederman M. Antimicrobial treatment of community- acquired pneumonia in adults: a conference report. Canadian Community-Acquired Pneumonia Consensus Conference Group. Can J Infect Dis. 1993;4:25. - PMC - PubMed
    1. Bartlett JG, Breiman RF, Mandell LA, File TM., Jr Community-acquired pneumonia in adults: guidelines for management. Infectious Diseases Society of America. Clin Infect Dis. 1998;26:811–38. - PubMed
    1. Gross PA, Barrett TL, Dellinger P, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis. 1994;18:421. - PubMed

MeSH terms